Clin2
NCT07417917Possibly a fitNot yet recruiting

Study of an oral medication for moderate to severe hidradenitis suppurativa

Adults With Moderate-to-severe Hidradenitis Suppurativa

Treatments studied

Part of Cancer, Immune system & allergy, Skin clinical trials.

This trial tests an oral capsule for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It may help when antibiotics haven't worked or can't be used.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
102 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have had hidradenitis suppurativa for at least 6 months.
  • Your condition is moderate to severe.
  • Antibiotics have not helped, or you cannot take them.
  • You have not had a heart attack, stroke, or heart failure in the last 6 months.
  • You have not used certain investigational drugs recently.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07225569Recruiting· Phase 2
Study of a new drug for moderate to severe hidradenitis suppurativa

This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.

Scottsdale, Arizona
NCT06932003Recruiting· Phase 1/Phase 2
Testing a new tablet for hidradenitis suppurativa

This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.

Beijing, Beijing Municipality
NCT06895499Recruiting· Phase 1/Phase 2
Testing a new drug for hidradenitis suppurativa

This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.

Jinan, Shandong
NCT07547813Recruiting· Phase 2
Testing LAD328 for moderate-to-severe hidradenitis suppurativa

This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.

Warsaw, Masovian Voivodeship
NCT07151937Recruiting· Phase 2
Testing LAD191 for moderate to severe hidradenitis suppurativa

This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.

Manises
NCT06058520Recruiting· Early Phase 1
Capsule microbiome transplant for hidradenitis suppurativa

This trial tests whether taking capsules containing healthy gut bacteria (fecal microbiota transplant) can help treat hidradenitis suppurativa. You may qualify if you have HS and haven't taken antibiotics in the last 30 days.

Minneapolis, Minnesota

Hear when a new Adults With Moderate-to-severe Hidradenitis Suppurativa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.